Our flyers offer insight into selected groups of products in peptide and oligonucleotide research.
Commerical Peptide NCE
Benefit from innovation, expertise and cutting-edge equipment that fits your needs from small to large-scale and from a GMP environment to develop and commercialize your peptide API therapeutic! With our operational excellence and customer-centric approach, we offer a clear Chemistry, Manufacturing and Control (CMC) plan for your project. Benefit from our technological leadership and innovation for higher
quality, capacity and sustainability.
Lanreotide
The long-acting somatostatin agonist Lanreotide (INN) was initially developed for the management of acromegaly, for which it has been approved in many countries. Consecutive studies showed that lanreotide alleviates symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome, and can serve as an alternative to octreotide in this field. Interestingly, lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogs, is being studied as a possible general anti-tumor agent.
Oligonucleotide therapeutics
The potential of oligonucleotide based drugs is finally receiving the focus it deserves. You can count on Bachem to bring a new level of innovation to help transform the lives of our customers and ultimately of patients.
Oligonucleotide therapeutics – Chinese
The potential of oligonucleotide based drugs is finally receiving the focus it deserves. You can count on Bachem to bring a new level of innovation to help transform the lives of our customers and ultimately of patients.
Oligonucleotide therapeutics – Japanese
The potential of oligonucleotide based drugs is finally receiving the focus it deserves. You can count on Bachem to bring a new level of innovation to help transform the lives of our customers and ultimately of patients.
Oligonucleotide therapeutics – Korean
The potential of oligonucleotide based drugs is finally receiving the focus it deserves. You can count on Bachem to bring a new level of innovation to help transform the lives of our customers and ultimately of patients.
Periodic Chart of Amino Acids
Our ‘Periodic Chart of Amino Acids’ gives you a short overview on the 20 proteinogenic amino acids, the common Fmoc- and Boc-strategy solid phase peptide synthesis (SPPS) protecting groups, and the absorption and emission characteristics of chromophores and fluorophores.
Periodic Chart of Unusual Alpha-Amino Acids
Our ‘Periodic Chart of Unusual α-Amino Acids’ lists a large selection of unusual α-amino acids and there commonly used abbreviations.
You Can Focus on your Masterpiece
We take care of everything else. Bachem in commercial generics.
